ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Medincell SA

Medincell SA (0ACH)

0.00
0.00
(0.00%)
終了 7月8日 12:30AM

Medincell SA (0ACH) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
-
( - )
買値
-
売値
-
出来高
-
平均取引量 (3 か月)
115,031 €
財務取引量
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
企業価値
1.08B
前日終値
-
始値
-
時刻
最終取引時間
VWAP
-
歳入
32.44M
純利益
-19.95M
発行済株式数
35,904,117
浮動株比率 (%)
91.31%
機関投資家保有比率 (%)
22.40%
配当利回り
PER
-46.6
株価売上高倍率 (PSR)
32.67
1 株当たり利益 (EPS)
-0.63
ベータ
1

Medincell SA について

MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophreni... MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults and bipolar I disorder. It is also developing mdc-TJK, a subcutaneous injection that is in the NDA preparation stage for the treatment of schizophrenia in adults; and mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation in total knee arthroplasty surgery. In addition, its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. It has strategic collaborations with AbbVie to develop, manufacture, and commercialize six long-acting injectable therapeutic products; and IM4TB to develop a long-acting injectable version of Macozinone for the treatment of tuberculosis. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France. 詳細を表示

セクター
-
業界
-
ウェブサイト
本社
Jacou, France
設立
2026
Medincell SA is listed in the sector of the ロンドン証券取引所 with ticker 0ACH. The last closing price for Medincell was -. Over the last year, Medincell shares have traded in a share price range of 0.00 € to 0.00 €.

Medincell currently has 35,904,117 shares in issue. Medincell has a price to earnings ratio (PE ratio) of -46.60.

0ACH 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0ACH - Frequently Asked Questions (FAQ)

What is the current Medincell SA share price?
The current share price of Medincell SA is 0.00 €
How many Medincell SA shares are in issue?
Medincell SA has 35,904,117 shares in issue
What is the 1 year trading range for Medincell SA share price?
Medincell SA has traded in the range of 0.00 € to 0.00 € during the past year
What is the PE ratio of Medincell SA?
The price to earnings ratio of Medincell SA is -46.6
What is the cash to sales ratio of Medincell SA?
The cash to sales ratio of Medincell SA is 32.67
What is the registered address of Medincell SA?
The registered address for Medincell SA is 3 Rue des Frères Lumière, Jacou, Languedoc-Roussillon, 34830
What is the Medincell SA website address?
The website address for Medincell SA is www.medincell.com

0ACH 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード